Abstract
The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Keywords: proteomics, human proteome, plasma proteomics
Current Proteomics
Title: Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Volume: 2 Issue: 1
Author(s): Sean R. Gallagher
Affiliation:
Keywords: proteomics, human proteome, plasma proteomics
Abstract: The Fourth Annual PepTalk meeting organized by the Cambridge Healthtech Institute on proteomics was held in San Diego, California from January 10 to 13, 2005. The entire meeting had an interesting name: Proteomics in a Six- Pack, and consisted of six individual meetings that ran for two days each, in two groups of concurrent sessions: (1) Fourth Annual Protein Arrays: Complex Challenges - Creative Solutions (January 10-11); (2) Eighth Annual Protein Expression (January 10-11); (3) Inaugural Protein Folding Disorders (January 10-11); (4) Second Annual Protein Process Development: Optimizing Protein Expression Through Scale-Up (January 12-13); (5) Fifth Annual The Human Proteome: Plasma Proteomics (January 12-13); and (6) Inaugural Protein Therapeutics: Minimizing Problems - Maximizing Production, Progress, and Potential (January 12-13). This was indeed what the organizers called the “protein information week”. This report summarizes The Human Proteome meeting, which ended with a joint closing plenary session with the Protein Process Development and the Protein Therapeutics meetings.
Export Options
About this article
Cite this article as:
Gallagher R. Sean, Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome, Current Proteomics 2005; 2 (1) . https://dx.doi.org/10.2174/1570164053507817
DOI https://dx.doi.org/10.2174/1570164053507817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications
Anti-Cancer Agents in Medicinal Chemistry The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research
Current Medicinal Chemistry MicroRNAs Implications in the Onset, Diagnosis, and Prognosis of Osteosarcoma
Current Molecular Medicine Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Current Drug Targets Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Calcium and Zinc DTPA Administration for Internal Contamination with Plutonium-238 and Americium-241
Current Pharmaceutical Biotechnology Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
Current Medicinal Chemistry Carbon Nanotubes for Biomaterials in Contact with Bone
Current Medicinal Chemistry Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases
Current Topics in Medicinal Chemistry Nanomedical Platform for Drug Delivery in Cancer
Current Organic Chemistry The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Current Topics in Medicinal Chemistry Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Current Pharmaceutical Design Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets Mesenchymal Stem Cells Regulate Cytoskeletal Dynamics and Promote Cancer Cell Invasion Through Low Dose Nitric Oxide
Current Molecular Medicine The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Regulation of HIPK Proteins by MicroRNAs
MicroRNA Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design